UR CTSI Pilot Study Identifies Memory “Fingerprints”

UR CTSI-supported researchers are the first to observe and quantify the differences between how people reimagine common scenarios. These unique neurological “fingerprints” could ultimately be used to understand, study and even improve the treatment of disorders such as Alzheimer’s disease.  

Past Pilot Awardee Granted $2M to Develop Better Statistics to Measure MicroRNA

With his first R01, Matthew McCall, Ph.D., will continue research that was previously funded by the UR CTSI. He aims to develop statistical methods to measure expression levels of microRNAs, which impact many human diseases. 

2020 Pilot Awards: Predicting Alzheimer’s, Heart Failure, Understanding Intellectual Disabilities

In July, three new pilot awardees began their UR CTSI-funded projects. Over the next year, the awardees will dissect the cellular and molecular causes of intellectual disabilities and develop new ways to predict Alzheimer's disease in seniors and heart failure in patients who need left ventricular assist devices (LVAD).

Just a Drop of Blood: An Easier Way to Test for COVID-19

UR CTSI Co-Director Martin Zand, M.D., Ph.D., is rapidly adapting previous flu research to develop a potential diagnostic test that would require just a few drops of blood to detect COVID-19 immunity.

From Sustaining a Concussion to Conducting Groundbreaking Brain Injury Research

As a young boy growing up in Somalia, Adnan Hirad suffered a concussion. Now - years later - he studies brain injury as an M.D./Ph.D. student in the UR CTSI’s Translational Biomedical Sciences PhD Program. His recent UR CTSI-funded study shows that sub-concussive head hits may damage the midbrain.